BLANDINO, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.580
EU - Europa 3.708
AS - Asia 3.070
SA - Sud America 543
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 14.255
Nazione #
US - Stati Uniti d'America 6.294
SG - Singapore 1.656
IT - Italia 1.243
CN - Cina 1.024
UA - Ucraina 794
IE - Irlanda 633
RU - Federazione Russa 579
BR - Brasile 472
CI - Costa d'Avorio 274
CA - Canada 250
VN - Vietnam 136
SE - Svezia 117
GB - Regno Unito 71
DE - Germania 69
FR - Francia 58
KR - Corea 53
IN - India 44
AR - Argentina 27
MX - Messico 26
PL - Polonia 25
SN - Senegal 23
ID - Indonesia 21
CH - Svizzera 20
BD - Bangladesh 19
EC - Ecuador 18
NL - Olanda 18
AT - Austria 17
HK - Hong Kong 16
UZ - Uzbekistan 16
IQ - Iraq 14
ZA - Sudafrica 14
TR - Turchia 13
PK - Pakistan 12
CO - Colombia 11
MA - Marocco 11
ES - Italia 10
CZ - Repubblica Ceca 9
EU - Europa 9
GR - Grecia 9
JP - Giappone 9
BE - Belgio 8
FI - Finlandia 7
LB - Libano 7
EG - Egitto 6
MY - Malesia 6
IR - Iran 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
KE - Kenya 4
LT - Lituania 4
RO - Romania 4
BJ - Benin 3
BO - Bolivia 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BS - Bahamas 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 14.255
Città #
Dallas 1.138
Singapore 868
Santa Clara 848
Jacksonville 758
Dublin 633
Chandler 578
Boardman 292
Abidjan 274
Nanjing 217
Ashburn 214
Chicago 198
Moscow 196
Toronto 181
Lawrence 180
Andover 178
Cambridge 178
Los Angeles 174
Beijing 138
Hefei 138
San Mateo 124
Wilmington 89
Milan 88
Des Moines 84
Catania 67
Nanchang 61
Shenyang 60
Civitanova Marche 55
Hebei 52
Seoul 52
Jiaxing 51
Rome 51
Ottawa 48
Ho Chi Minh City 47
Saint Petersburg 44
Tianjin 39
Houston 34
São Paulo 34
Changsha 33
Hanoi 29
Bremen 25
Buffalo 25
Dakar 23
Columbus 22
Florence 19
The Dalles 18
Council Bluffs 17
Boston 16
Rio de Janeiro 16
Brooklyn 15
Palermo 15
London 14
New York 14
Warsaw 14
Bologna 13
Hangzhou 13
Phoenix 13
Stockholm 13
Atlanta 12
Belo Horizonte 12
Da Nang 12
Norwalk 12
Seattle 12
Verona 12
Cherasco 11
Dhaka 11
Hong Kong 11
Pune 11
Turin 11
Ann Arbor 10
Genoa 10
Curitiba 9
Jinan 9
Johannesburg 9
Mexico City 9
Angri 8
Brussels 8
Chennai 8
Den Haag 8
Frankfurt Am Main 8
Jakarta 8
Kunming 8
Montreal 8
Ribeirão Preto 8
San Francisco 8
Segrate 8
Tokyo 8
Ankara 7
Brasília 7
Grafing 7
Liberty Lake 7
Modena 7
Mumbai 7
Quito 7
Washington 7
Baghdad 6
Campinas 6
Charlotte 6
Haiphong 6
Leawood 6
Porto Alegre 6
Totale 9.199
Nome #
Caratteristiche di adesione di ceppi di Bifidobacterium lactis BB-12, Bifidobacterium longum W11, Bifidobacterium bifidum su cellule epiteliali umane della linea HT-29 1.014
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 151
Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy 141
3-Methylthio-, 3-(amino-substituted)ethylthio-, 3-carboxymethylthio-, 3,3'-(dithiobis)-5-aryl-4H(R)-1,2,4-triazoles and 2-aminomethyl-N-substituted derivatives of 5-aryl-4H(R)-1,2,4-triazolin-3-thione: synthesis and biological activity 139
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum 138
Batteri anaerobi non sporigeni. In: MICROBIOLOGIA FARMACEUTICA 125
Ampliamento dello spettro di attività della vancomicina nei confronti di batteri gram-negativi mediante incapsulazione in liposomi fuso genici 123
Impact of gut microbiota on diabetes mellitus 119
CARATTERISTICHE DI ADESIONE DI CEPPI DI BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BB-12, BIFIDOBACTERIUM LONGUM W11, BIFIDOBACTERIUM BIFIDUM SU CELLULE EPITELIALI UMANE DELLA LINEA HT-29 117
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 113
Microbial and clinical effects of systemic flurithromycin therapy in the treatment of periodontal diseases compared with clinical procedures 112
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 112
Activity of Berberis aetnensis C. Presl. Root extract against Candida strains 110
Microbial evaluation of "in vitro" antibacterial activity of "one stage full mouth" disinfection with clorexidine in adult periodontitis 109
Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases 105
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections 105
Antimicrobial susceptibility and Beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections 103
Antibacterial activity of medicinal plant extracts against periodontopathic bacteria 102
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 101
In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates 100
Attività antibatterica di cefprozil nei confronti di Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis e Streptococcus pneumoniae circolanti attualmente in Italia 99
BACTERIOLOGICAL STUDIES OF AMOXYCILLIN-CLAVULANIC ACID AGAINST ANEROBIC BACTERIA. 99
SENSITIVITY TO AUGMENTIN OF ANEROBIC BACTERIA BETA-LACTAMASES PRODUCING. 98
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 98
Bacilli sporigeni aerobi e anaerobi (cap. 37) 97
Antimicrobial susceptibility of Lactobacillus strains used in probiotic products 97
Bacilli sporigeni aerobi ed anerobi. In: MICROBIOLOGIA FARMACEUTICA 96
Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens 96
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 95
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints 95
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 94
DIMINUITA PRESENZA DI FATTORI DI VIRULENZA IN ESCHERICHIA COLI UROPATOGENI ANTIBIOTICO-RESISTENTI 93
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 93
Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery 93
Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles 91
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 91
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and beta-lactamase production 91
Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut 91
Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones 90
Studio microbiologico dell’attività antibatterica “in vivo” della disinfezione “one stage full mouth” con clorexidina nella terapia della parodontite dell’adulto 90
Synthesis of 1-aroyl-4H(R)-thiosemicarbazides, the corresponding 5-aryl 4H(R)-1,2,4-triazolin-3-thiones and some derivatives of pharmaceutical interest 89
Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections 89
Meccanismi patogenetici di ceppi di Prevotella intermedia e Fusobacterium nucleatum isolati da parodontopatie e da infezioni polmonari 89
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 89
Synthesis and preliminary biological investigation of 2,6-diaryl substituted imidazo(1,2-b)-1,3-4-thiadiazoles [SINTES]I E VALUTAZIONE BIOLOGICA PRELIMINARE DI IMIDAZO[2,1-b]-1,3,4-TIADIAZOLI-2,6-DIARILSOSTITUITI 88
Microbiological characteristics of kanendomycin [Caratteristiche microbiologiche della kanendomicina] 88
Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis 87
Identification and characterization of Lactobacillus paracasei strain with probiotic properties isolated from faeces of healthy adult volunteers 87
Epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated from 2001 to 2005 in Catania 87
Dental implants with locking taper connection versus screwed connection: microbiologic and scanning electron microscope study 86
Uso di prebiotici e probiotici ed ecosistema microbico intestinale 86
Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin 86
Synthesis, spectral behaviour and microbiological properties of some di(nitrothienyl)sulfides. 86
Osservatorio Epidemiologico Italiano: analisi del secondo anno di monitoraggio delle resistenze agli antibiotici in Haemophilus influenzae e Haemophilus parainfluenzae 85
Study on the adhesion characterstics of Bifidobacterium spp.strains on human epithelial cell line HT-29. 85
Parodontopatia dell'adulto: 3 terapie a confronto 85
Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy 84
In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections 84
Microbiological intraoperative results in short-term prophylaxis (aztreonam or gentamicin) in abdominal surgery 84
Probiotics:overview of microbiological and immunological characteristics 84
Predictive value of bacterial analysis of laparotomy wounds 83
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 83
Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain 83
Intercellular communication during yeast cell growth 82
SURGICAL SITE INFECTION IN ELDERLY PATIENTS 82
Osservatorio Epidemiologico Italiano. Patogeni respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 82
Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains 82
Incidence of non-fermenting gram-negative bacilli in infected patients 81
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 81
Probiotici e Prebiotici:dalla ricerca al consumatore 81
Bacteriological findings and antimicrobial resistance in odontogenic and non odontogenic chronic maxillary sinusitis 80
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 80
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 79
Susceptibility of clinical isolates of Haemophilus to new 4-quinolones 79
Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery 79
CT findings in hepatic involvement by Echinococcus granulosus 78
PRODUZIONE DI B-LATTAMASI ED ANTIBIOTICO SENSIBILITA’ DI GERMI ANAEROBI. 78
Effetto prebiotico di Opuntia ficus-indica (L.) nei confronti di alcuni ceppi di Lactobacillus e Bifidobacterium isolati da prodotti probiotici farmaceutici 78
Immunizzazione passiva naturale e artificiale. In: MICROBIOLOGIA FARMACEUTICA 78
Prevenzione e controllo delle infezioni in chirurgia gastrica 77
Studio microbiologico dell'attività "in vivo"della disinfezione "one stage full mouth"con clorexidina nella terapia della parodontite dell'adulto 77
Caratteristiche microbiologiche e terapeutiche dei batteri probiotici 77
Correlations between bacterial flora present in the juice and the gastric mucosa and the risk of postoperative infection [Correlazione tra flora batterica presente nel succo e nella mucosa gastrica e rischio di infezione postoperatoria] 76
Evaluation of the antibacterial effect of cefsulodin against Pseudomonadaceae [Valutazione dell'attività antibatterica del cefsulodin nei confronti di Pseudomonadaceae] 76
Impianti dentali a connessione conometrica versus impianti dentali a connessione avvitata:studio microbiologico e al microscopio elettronico a scansione 75
Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units [Azione antimicotica di alcuni diaril solfuri a catena aperta e ciclici contenenti unità piridiniche e tiadiazoliche] 75
Batteri anaerobi non sporigeni (cap. 38) 75
Virulence factors and antibiotic resistance in uropathogenic Escherichia coli 75
L'ambiente intestinale e la disbiosi 75
Susceptibility of molecularly characterizeted hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin 74
In vitro activity of imipenem towards gram-negative bacilli 73
Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam) 72
Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination 71
Incidence of fermentative and non-fermentative gram-negative bacilli in an intensive care environment [Incidenza di bacilli gram-negativi fermentanti e non fermentanti in ambiente nosocomiale di terapia intensiva] 71
SUSCEPTIBILITY OF CLINICAL ISOLATES OF ENTEROBACTERIACEAE TO CEFDINIR (CI 983, FK 482) 70
Internalization–associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis 70
In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents 70
Incidence and antibiotic-resistance of gram-negative species isolated from burns [Incidenza antibiotico-resistenza di specie batteriche gram-negative isolate in ustionati] 69
Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin 68
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 66
Totale 9.915
Categoria #
all - tutte 45.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 46 158 15 145 17 173 55
2021/20221.384 197 184 13 33 208 8 200 43 161 3 54 280
2022/20231.919 189 60 26 132 244 344 13 303 511 23 56 18
2023/2024798 49 116 39 66 36 78 29 60 23 48 163 91
2024/20253.144 39 485 200 144 787 269 32 122 248 324 189 305
2025/20263.978 441 398 1.407 386 980 366 0 0 0 0 0 0
Totale 14.502